IFRX — InflaRx N.V.
Price · 2024-08-26 → 2026-08-21
499 daily closes shownAnonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2017-11-08.
Performance
Technicals
Others in Healthcare
Measured signals that fired on IFRX
| date | signal | measured base rate |
|---|---|---|
| 2026-05-14 | Short volume far above its own normal short | -0.76% over 21 days · t = -2.79 · n = 5,897 statistically distinguishable from its control group |
| 2026-05-07 | Breakout to a 52-week high price | -1.00% over 21 days · t = -8.58 · n = 24,386 statistically distinguishable from its control group |
Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →
Largest institutional holders
| manager | value | shares |
|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | 7.1M | 7.9M |
| 683 Capital Management, LLC | 3.0M | 3.3M |
| BANK OF AMERICA CORP /DE/ | 1.8M | 2.0M |
| Eversept Partners, LP | 1.6M | 1.8M |
| MORGAN STANLEY | 1.1M | 1.2M |
| MARSHALL WACE, LLP | 493.4K | 554.4K |
| RAYMOND JAMES FINANCIAL INC | 354.0K | 395.8K |
| Squarepoint Ops LLC | 270.1K | 302.0K |
| T3 Companies, LLC | 260.3K | 291.0K |
| TWO SIGMA INVESTMENTS, LP | 169.1K | 189.1K |
13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →
Latest SEC filings
| form | filed | period | |
|---|---|---|---|
| SCHEDULE 13G/A | 2026-08-14 | — | on EDGAR ↗ |
| 424B5 | 2026-08-14 | — | on EDGAR ↗ |
| SCHEDULE 13G | 2026-08-14 | — | on EDGAR ↗ |
| SCHEDULE 13G/A | 2026-08-14 | — | on EDGAR ↗ |
| EFFECT | 2026-08-12 | — | on EDGAR ↗ |
| SCHEDULE 13G | 2026-08-06 | — | on EDGAR ↗ |
| F-3 | 2026-08-06 | — | on EDGAR ↗ |
| S-8 | 2026-08-06 | — | on EDGAR ↗ |
Short selling
This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →
Recent headlines
- InflaRx N.V. (IFRX) filed form SCHEDULE 13G/A · 2026-08-14 · SEC EDGAR
- InflaRx N.V. (IFRX) filed form 424B5 · 2026-08-14 · SEC EDGAR
- InflaRx N.V. (IFRX) filed form SCHEDULE 13G · 2026-08-14 · SEC EDGAR
- InflaRx N.V. (IFRX) filed form SCHEDULE 13G/A · 2026-08-14 · SEC EDGAR
Ask the AI about IFRX
The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.
Everything on this page is live in the terminal.
Charts, filings, insider flow and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →
